KR100650797B1 - Method for preparing optically active cyclopropane carboxamide - Google Patents
Method for preparing optically active cyclopropane carboxamide Download PDFInfo
- Publication number
- KR100650797B1 KR100650797B1 KR1020050122129A KR20050122129A KR100650797B1 KR 100650797 B1 KR100650797 B1 KR 100650797B1 KR 1020050122129 A KR1020050122129 A KR 1020050122129A KR 20050122129 A KR20050122129 A KR 20050122129A KR 100650797 B1 KR100650797 B1 KR 100650797B1
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- carboxylic acid
- unsubstituted
- cyclopropane
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 39
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 9
- 239000011149 active material Substances 0.000 claims abstract description 7
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 7
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 7
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 4
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 108090001060 Lipase Proteins 0.000 claims description 24
- 102000004882 Lipase Human genes 0.000 claims description 24
- 239000004367 Lipase Substances 0.000 claims description 23
- 235000019421 lipase Nutrition 0.000 claims description 23
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- -1 halo compound Chemical group 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 4
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 239000003849 aromatic solvent Substances 0.000 claims description 2
- 125000005997 bromomethyl group Chemical group 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 claims description 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 31
- 108090000790 Enzymes Proteins 0.000 abstract description 31
- 230000003287 optical effect Effects 0.000 description 50
- 238000002360 preparation method Methods 0.000 description 19
- 238000006911 enzymatic reaction Methods 0.000 description 18
- YBZQRYWKYBZZNT-SCSAIBSYSA-N (1s)-2,2-dimethylcyclopropane-1-carboxamide Chemical compound CC1(C)C[C@@H]1C(N)=O YBZQRYWKYBZZNT-SCSAIBSYSA-N 0.000 description 9
- VEQMUQZKBLIXLT-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1C(C)C1C(O)=O VEQMUQZKBLIXLT-UHFFFAOYSA-N 0.000 description 9
- 150000001298 alcohols Chemical class 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108090000371 Esterases Proteins 0.000 description 4
- 241001661345 Moesziomyces antarcticus Species 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 2
- QXUCJWJDQBHKOM-UHFFFAOYSA-N 2,2,2-trichloroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCC(Cl)(Cl)Cl QXUCJWJDQBHKOM-UHFFFAOYSA-N 0.000 description 2
- JLTBCXJPWXTLEJ-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical class CC1(C)CC1C(=O)OCC(F)(F)F JLTBCXJPWXTLEJ-UHFFFAOYSA-N 0.000 description 2
- RXMTUVIKZRXSSM-UHFFFAOYSA-N 2,2-diphenylethanamine Chemical class C=1C=CC=CC=1C(CN)C1=CC=CC=C1 RXMTUVIKZRXSSM-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- RMVIMWRFBQNSKR-UHFFFAOYSA-N 2-bromoethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCCBr RMVIMWRFBQNSKR-UHFFFAOYSA-N 0.000 description 2
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- QLLRZRXEQPAGQA-UHFFFAOYSA-N 2-chloroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCCCl QLLRZRXEQPAGQA-UHFFFAOYSA-N 0.000 description 2
- LPTHEVLJSVAPLO-UHFFFAOYSA-N 2-methoxyethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound COCCOC(=O)C1CC1(C)C LPTHEVLJSVAPLO-UHFFFAOYSA-N 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 150000000083 (-)-menthol derivatives Chemical class 0.000 description 1
- 0 *C(C1)([C@@]1C(N)=O)I Chemical compound *C(C1)([C@@]1C(N)=O)I 0.000 description 1
- YHKJSIVFPYFAJL-UHFFFAOYSA-N 2,2,2-trifluoroethyl cyclopropanecarboxylate Chemical class FC(F)(F)COC(=O)C1CC1 YHKJSIVFPYFAJL-UHFFFAOYSA-N 0.000 description 1
- OGZJULUCZAZKHP-UHFFFAOYSA-N 2,2-dibromoethanol Chemical compound OCC(Br)Br OGZJULUCZAZKHP-UHFFFAOYSA-N 0.000 description 1
- IDJOCJAIQSKSOP-UHFFFAOYSA-N 2,2-dichloroethanol Chemical compound OCC(Cl)Cl IDJOCJAIQSKSOP-UHFFFAOYSA-N 0.000 description 1
- VOGSDFLJZPNWHY-UHFFFAOYSA-N 2,2-difluoroethanol Chemical compound OCC(F)F VOGSDFLJZPNWHY-UHFFFAOYSA-N 0.000 description 1
- YBZQRYWKYBZZNT-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxamide Chemical class CC1(C)CC1C(N)=O YBZQRYWKYBZZNT-UHFFFAOYSA-N 0.000 description 1
- BFNMOMYTTGHNGJ-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)CC1C(O)=O BFNMOMYTTGHNGJ-UHFFFAOYSA-N 0.000 description 1
- IDBOZJGFRCKBGY-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carboxamide Chemical compound CC1C(C)C1C(N)=O IDBOZJGFRCKBGY-UHFFFAOYSA-N 0.000 description 1
- GGDYAKVUZMZKRV-UHFFFAOYSA-N 2-fluoroethanol Chemical compound OCCF GGDYAKVUZMZKRV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ITATYELQCJRCCK-UHFFFAOYSA-N Mandelic Acid, Methyl Ester Chemical compound COC(=O)C(O)C1=CC=CC=C1 ITATYELQCJRCCK-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 description 1
- 229960004912 cilastatin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ITATYELQCJRCCK-QMMMGPOBSA-N methyl (2s)-2-hydroxy-2-phenylacetate Chemical compound COC(=O)[C@@H](O)C1=CC=CC=C1 ITATYELQCJRCCK-QMMMGPOBSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229950004616 tribromoethanol Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 효소를 이용하여 화학식 1의 사이클로프로판 카복사미드 광학활성물질을 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing a cyclopropane carboxamide optically active material of Chemical Formula 1 using an enzyme.
[화학식 1][Formula 1]
상기 식에서 R1, R2는 서로 동일하거나 상이할 수 있으며, 수소, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알킬, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알케닐, 벤질, 치환되거나 치환되지 않은 C3 내지 C7의 사이클로알킬, 치환되거나 치환되지 않은 아릴알킬 또는 치환되거나 치환되지 않은 헤테로아릴알킬 중에서 선택되어진다.Wherein R 1 , R 2 may be the same or different from each other, and hydrogen, substituted or unsubstituted straight or branched C1 to C7 alkyl, substituted or unsubstituted straight or branched C1 to C7 alkenyl, benzyl , Substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, or substituted or unsubstituted heteroarylalkyl.
Description
본 발명은 효소를 이용하여 사이클로프로판 카복사미드 광학활성물질을 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing a cyclopropane carboxamide optically active substance using an enzyme.
치환된 사이클로프로판 카복실산, 특히 광학활성을 갖는 2,2-디메틸사이클로프로판카복실산은 디하이드로펩티다제 I 억제제 및 포유동물에 독성이 매우 적은 피레스테로이드계 살충제의 원료로 이용되고(영국공개특허공보 제1,260,847호), 카바페넴계 항생제가 신장에서 분해되는 것을 막는 실라스타틴의 핵심중간체(유럽특허 제48,301호, 유럽특허 제48,025호) 및 광학분활제로 사용되는 중요물질로서 그 용도가 다양하게 개발되는 중요한 산업적 의미를 갖는 키랄 빌딩블럭이다.Substituted cyclopropane carboxylic acids, in particular 2,2-dimethylcyclopropanecarboxylic acid with optical activity, are used as raw materials for dihydropeptidase I inhibitors and pyresteroid-based pesticides with very low toxicity to mammals. 1,260,847), the key intermediates used in Cilastatin (European Patent No. 48,301, European Patent No. 48,025) and optical splitting agents to prevent carbapenem antibiotics from being broken down in the kidneys. It is a chiral building block with an industrial meaning.
기존 제조 공정을 보면 크게 광활성 아민류나 하이드록시기를 갖는 L-멘톨이나 (S)-만델산 에스터를 이용하여 에스터를 제조한 후 반복되는 재결정을 통해 제 조하는 방법과 발효공정을 통해 원하는 (S)-폼의 제품을 제조하는 공정으로 나눌 수 있다. 두 가지 공정 모두 제품의 낮은 광학 순도, 낮은 수율, 고가의 광학분할 시약 사용 및 반복적인 재결정 공정을 수반해야 하는 여러 단점들 중 몇 가지는 꼭 수반되기 때문에 산업적으로는 제약을 갖는 공정들이라 할 수 있다.In the existing manufacturing process, an ester is prepared using L-menthol or (S) -mandelic acid ester having photoactive amines or hydroxy groups, and is prepared by repeated recrystallization and the desired (S) through fermentation process. It can be divided into the process of manufacturing the product of the foam. Both processes are industrially constrained because of the several disadvantages that must involve low optical purity of the product, low yield, use of expensive optical splitting reagents, and repetitive recrystallization processes.
또한 미국특허공보 제4,542,235호에 의하면 키랄 (S)-디메틸 사이클로프로판 카복실산을 제조하기 위해 다양하게 치환된 광활성 디페닐에틸아민을 광학분할제로 사용하고 있으나 상기 발명에서 사용되는 치환된 키랄 디페닐에틸아민은 일반적으로 구하기 힘든 고가의 시약으로 제조원가를 매우 높일 뿐만 아니라, 재결정을 2회 이상해야 하며, 재결정시 과량의 용매를 사용해야 하는 단점을 갖고 있고, L-멘톨을 이용하여 광학분할을 개시하고 있는 미국특허공보 제4,487,956호의 경우 높은 수율과 높은 광학 순도의 측면에서는 유용한 방법이나 후처리 공정이 매우 복잡하고 비교적 비싼 L-멘톨을 사용해야 하는 단점이 있다. 미국특허공보 제5,166,417호에는 광활성 L-(3-메톡시페닐)에틸아민을 이용하여 다이아스테레오머(Diastereomer)를 제조한 후 이를 재결정 방법에 의한 광학분할을 개시하고 있으나, 매우 고가의 키랄 아민을 사용할 뿐만 아니라 수율이 21% 수준으로 매우 낮았고 제조된 (S)-디메틸 사이클로프로판 카복실산의 광학순도가 93 %이하이므로, 상업적인 유용성이 부족하였다.In addition, U.S. Patent No. 4,542,235 discloses the use of various substituted photoactive diphenylethylamines as optical splitting agents to prepare chiral (S) -dimethyl cyclopropane carboxylic acid, but the substituted chiral diphenylethylamines used in the present invention. Is an expensive reagent that is generally difficult to obtain, and it has the disadvantage of not only increasing the manufacturing cost but also recrystallization twice or more, and using excessive solvent when recrystallization. Patent No. 4,487,956 has a disadvantage in that a useful method or post-treatment process is very complicated and relatively expensive L-menthol should be used in view of high yield and high optical purity. U.S. Patent No. 5,166,417 discloses optical splitting by preparing a diastereomer using photoactive L- (3-methoxyphenyl) ethylamine and then recrystallizing the same. As well as use, the yield was very low, at a level of 21% and the optical purity of the prepared (S) -dimethyl cyclopropane carboxylic acid was 93% or less, thus lacking commercial utility.
일본특허 공개기보 제80-051023호에는 퀴닌을 이용한 광학분활 방법을 사용하여 (S)-디메틸 사이클로프로판 카복실산을 제조하는 방법이 공지되어 있으나, 퀴닌이 매우 고가이고 안정적으로 공급이 되지 않는 단점이 있을 뿐만 아니라 수율이 낮다는 단점이 있었다. 또한 영국공개특허공보 제1260847호에는 D- 또는 L-페네틸아민을 광학분할에 사용하는 방법이 공개되어 있으나, 상기 방법에 의하여 제조되는 (S)-디메틸 사이클로프로판 카복실산의 광학 순도가 49 % 밖에 되지 않고 수율이 낮아 산업적 유용성이 떨어지는문제점이 있었다.Japanese Patent Laid-Open Publication No. 80-051023 discloses a method for preparing (S) -dimethyl cyclopropane carboxylic acid using an optical splitting method using quinine, but quinine is very expensive and may not be supplied stably. In addition, the yield was low. In addition, British Patent Publication No. 1260847 discloses a method of using D- or L-phenethylamine for optical splitting, but the optical purity of (S) -dimethyl cyclopropane carboxylic acid prepared by the above method is only 49%. In addition, the yield was low, there was a problem that the industrial usefulness falls.
또한 미국특허공보 제5,243,070호에서는 디메틸사이클로프로판 카복실산을 키랄 만델산 메틸 에스터와 반응시켜 디메틸사이클로프로판 카복실산 에스터 라세미체를 제조한 후 이를 재결정 방법으로 광학분할을 한 후 이를 가수분해하여 (S)-디메틸사이클로프로판 카복실산을 제조한 후 키랄분리시약과 이성질체를 분리하는 분리(resolution)과정을 거쳐 디메틸사이클로프로판카복사미드를 제조하는 방법을 개시하고 있으나 이때 사용되는 (S)-만델산 메틸 에스터가 고가의 시약이고 광학순도를 높이기 위해 재결정을 3회 이상 반복해야 되는 단점이 있다.In addition, U.S. Patent No. 5,243,070 discloses that dimethylcyclopropane carboxylic acid is reacted with chiral mandelic acid methyl ester to prepare dimethylcyclopropane carboxylic acid ester racemate, which is then optically divided by recrystallization method, and then hydrolyzed to (S)- A method of preparing dimethylcyclopropanecarboxamide is disclosed by preparing a dimethylcyclopropane carboxylic acid and then performing a resolution process of separating a chiral separation reagent and an isomer, but the (S) -mandelic acid methyl ester used at this time is expensive. It is a reagent of and has the disadvantage of repeating recrystallization three or more times to increase optical purity.
가장 최근에 공개된 방법으로 발효공정을 이용한 방법인 미국특허공보 제5,273,903호, 미국특허공보 제5,360,731호의 방법은 다양한 미생물을 이용하여 2,2-디메틸사이클로프로판 카복사미드 라세미체를 선택적 분해 반응을 이용하여 (S)-디메틸사이클로프로판 카복사미드를 제조하는 방법을 제시하고 있지만, 상기 발명들은 미생물을 미리 배양하는데 2일이나 걸리는 번거로움과 반응공정 및 분리공정의 복잡함을 가질 뿐만 아니라 반응기질 농도가 2 % 수준으로 상업성이 떨어지는 것이 문제점으로 제시되고 있다. Most recently published methods using the fermentation process US Patent No. 5,273,903, US Patent No. 5,360,731 method is a selective decomposition reaction of 2,2-dimethylcyclopropane carboxamide racemate using a variety of microorganisms Although a method for preparing (S) -dimethylcyclopropane carboxamide is proposed using the above-described invention, the present invention not only has two days to incubate microorganisms in advance, but also has a complicated reaction and separation process, The problem is that the concentration falls to 2%.
한편 국제공개특허공보 제 2004/5241호에는 에스터라제를 이용한 광학분할 반응을 하여 (S)-디메틸사이클로프로판 카복실산을 제조하는 방법을 개시하고 있으 나, 효소에 의한 광학분할은 특정구조들의 화합물에 대하여 모든 효소들이 광학분할의 효과를 갖는 것이 아닌 특정효소에 의해서만 상응하는 광학분할이 이루어지고, 더 나아가, 광학분할에 이용되는 리파제라 하더라도 그 소스(source)에 따라, 작용하는 화합물의 종류, 작용하는 광학 이성질체의 종류 및 반응성 등에서 차이가 있음을 바탕으로 본다면, 에스터라제를 미생물의 범주로 혼동하여 기재하고 있을 뿐만 아니라 명세서의 실시예에서는 사용하고 있는 에스터라제가 구체적으로 어느 것인지 특정하여 기재되어 있지 아니하여 실질적으로 효소를 이용한 (S)-디메틸사이클로프로판 카복실산 광학분할을 공지하고 있다고 하기가 어렵다.On the other hand, International Patent Publication No. 2004/5241 discloses a method for preparing (S) -dimethylcyclopropane carboxylic acid by optical splitting reaction using esterase, but the optical splitting by enzyme is applied to compounds of specific structures. Not all enzymes have the effect of optical splitting, but the corresponding optical splitting is performed only by a specific enzyme, and furthermore, even if the lipase used for the optical splitting, depending on its source, the kind and function of the compound Based on the difference in the kind and reactivity of the optical isomer, the esterase is not only confused with the category of the microorganism but also the specific examples of the esterase being used are described in the Examples of the specification. (S) -dimethylcyclopropane carboxylic acid substantially without enzyme It is difficult to say that optical splitting is known.
대한민국공개특허 제10-2004-0004744호에는 디메틸사이클로프로판 카복실산을 알콜과 반응시켜 디메틸사이클로프로판 카복실산 에스테르 라세미체를 제조한 후 미생물을 이용한 생물학적 분리법(biological resolution)으로 (S)-디메틸사이클로프로판 카르복실산과 (R)-디메틸사이클로프로판 카르복실산을 제조하고, 상기 제조된 (S)-디메틸사이클로프로판 카르복실산을 다양한 염소화 시약 및 암모니아와 부가반응을 시켜 (S)-디메틸싸이클로프로판카복사미드를 제조하는 방법이 공지되어 있다. 그러나 상기의 방법은 (S)-디메틸사이클로프로판 카르복실산과 (R)-디메틸사이클로프로판 카르복실산이 반응액 내에 공존하기 때문에 (S)-디메틸사이클로프로판 카르복실산을 따로 분리하는 추출공정을 거쳐야 하고 상기 추출공정으로 인하여 다량의 유기용매를 사용해야하며, 또한 (S)-디메틸싸이클로프로판카복사미드를 제조하기 위하여 추출된 (S)-디메틸사이클로프로판 카르복실산과 염소화 시약 및 암모니아를 반응시키는 아미드 제조반응 공정을 거쳐야 하기 때문에 반응공정이 길어 져 수율이 낮아지는 문제점이 있었다. 또한 물에 불용성인 에스테르 화합물을 가수분해 반응시킴으로서 반응 중에 효소가 뭉쳐지는 문제점이 발생하였다.Korean Patent Publication No. 10-2004-0004744 discloses a dimethylcyclopropane carboxylic acid ester racemate by reacting dimethylcyclopropane carboxylic acid with an alcohol, and then (S) -dimethylcyclopropane carbon by biological resolution using microorganisms. Acid and (R) -dimethylcyclopropane carboxylic acid were prepared, and the (S) -dimethylcyclopropane carboxylic acid prepared above was subjected to addition reaction with various chlorination reagents and ammonia to (S) -dimethylcyclopropanecarboxamide. Methods of preparing are known. However, since the (S) -dimethylcyclopropane carboxylic acid and (R) -dimethylcyclopropane carboxylic acid coexist in the reaction solution, the above-mentioned method must undergo an extraction step of separately separating (S) -dimethylcyclopropane carboxylic acid. Due to the extraction process, a large amount of organic solvent must be used, and an amide preparation reaction in which (S) -dimethylcyclopropane carboxylic acid, chlorination reagent and ammonia are reacted to prepare (S) -dimethylcyclopropanecarboxamide Since the process has to go through a long process, there is a problem that the yield is lowered. In addition, the hydrolysis reaction of the ester compound insoluble in water caused a problem that the enzyme is agglomerated during the reaction.
본 발명의 발명자들은 사이클로프로판 카복실산 에스터 라세미체를 암모니아 가스가 용해된 유기용매 중에서 효소로 칸디다 안타크티카 유래의 리파제를 넣고 반응시킬 때만 (S)-폼의 치환된 사이클로프로판 카복실산 에스터만이 특이적으로 반응되어 반응액 내에는 (S)-폼의 치환된 사이클로프로판 카복사미드와 (R)-폼의 치환된 사이클로프로판 카복실산 에스터를 제조하게 되었으며, 따라서, 본 발명의 목적은 종래의 광학활성을 갖는 아민류나 L-멘톨 같은 값비싼 광학 분활제를 사용하거나 복잡한 발효공정을 사용하지 않고 고농도에서 가수분해 효소를 반응시켜 (S)-사이클로프로판 카복사미드 유도체를 높은 광학순도, 고수율의 산업적으로 경제성이 있는 새로운 제조방법을 제공하는 것이다.The inventors of the present invention are specific to the substituted cyclopropane carboxylic acid ester of (S) -form only when the cyclopropane carboxylic acid ester racemate is reacted with an lipase derived from Candida anthracica as an enzyme in an organic solvent in which ammonia gas is dissolved. The reaction was carried out to prepare a substituted cyclopropane carboxamide of (S) -form and a substituted cyclopropane carboxylic acid ester of (R) -form in the reaction solution. Accordingly, an object of the present invention is to provide a conventional optical activity. (S) -cyclopropane carboxamide derivatives can be converted to high optical purity and high yield by reacting hydrolytic enzymes at high concentrations without using expensive optical splitting agents such as amines and L-menthols or complex fermentation processes. It is to provide a new manufacturing method that is economical.
본 발명은 효소를 이용하여 키랄 치환된 사이클로프로판 카복사미드 이성질체(Chiral Substituted Cyclopropane Carboxamide)를 제조하는 새로운 방법에 관한 것이다. 상세하게는 (1) 화학식 3의 사이클로프로판 카복실산 에스터 라세미체를 암모니아 가스가 용해된 유기용매 중에서 일정한 반응온도 하에서 칸디다 안타크티카 유래의 리파제와 반응시키는 단계 및 (2) 화학식 1의 (S)-사이클로프로판 카복 사미드 화합물과 화학식 2의 (R)-사이클로프로판 카복실산 에스터 화합물을 분리하는 단계를 포함하는 광학활성물질인 사이클로프로판 카복사미드 및 사이클로프로판 카복실산 에스터를 제조하는 방법을 특징으로 한다.The present invention relates to a novel method for preparing chiral substituted cyclopropane carboxamide isomers using enzymes. Specifically, (1) reacting the cyclopropane carboxylic ester racemate of Formula 3 with a lipase derived from Candida anthtacica under a constant reaction temperature in an organic solvent in which ammonia gas is dissolved, and (2) And a method for preparing cyclopropane carboxamide and cyclopropane carboxylic acid ester, which are optically active materials comprising the step of separating the cyclopropane carboxamide compound and the (R) -cyclopropane carboxylic acid ester compound of the formula (2).
[화학식 1][Formula 1]
[화학식 2][Formula 2]
[화학식 3][Formula 3]
[상기 화학식 1 내지 3의 R1, R2는 서로 동일하거나 상이할 수 있으며, 수소, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알킬, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알케닐, 벤질, 치환되거나 치환되지 않은 C3 내지 C7의 사이클로알킬, 치환되거나 치환되지 않은 아릴알킬 또는 치환되거나 치환되지 않은 헤테로아릴알킬 중에서 선택되어진 것이고; R3, R4는 서로 동일하거나 상이할 수 있으며, 수소, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알킬, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알케닐, 벤질, 치환되거나 치환되지 않은 C3 내지 C7의 사이클로알킬, 치환되거나 치환되지 않은 아릴알킬 또는 치환되거나 치환되지 않은 헤테로아릴알킬 중에서 선택되어진 것이고; R5는 C1 내지 C7의 직쇄 또는 측쇄의 알킬, 할로화합물로 치환된 C1 내지 C7의 직쇄 또는 측쇄의 알킬 또는 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알콕시기가 치환된 C1 내지 C7의 직쇄 또는 측쇄의 알킬 중에서 선택되어진 것이다.][R 1 , R 2 of the above Chemical Formulas 1 to 3 may be the same or different from each other, hydrogen, substituted or unsubstituted straight or branched C1 to C7 alkyl, substituted or unsubstituted straight or branched C1 to C7 Alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl or substituted or unsubstituted heteroarylalkyl; R 3 , R 4 may be the same as or different from each other, and are hydrogen, substituted or unsubstituted straight or branched C1 to C7 alkyl, substituted or unsubstituted straight or branched C1 to C7 alkenyl, benzyl, substituted Or substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, or substituted or unsubstituted heteroarylalkyl; R 5 is C1 to C7 linear or branched alkyl, C1 to C7 substituted with halo compound, C1 to C7 straight or branched alkyl or substituted or unsubstituted straight or branched C1 to C7 alkoxy group substituted C1 to C7 straight chain Or branched alkyl.]
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 화학식 3의 사이클로프로판 카복실산 에스터 라세미체를 암모니아 가스가 용해된 유기용매 중에서 리파제 효소를 넣고 반응온도를 일정하게 유지시키면서 반응시키면 (S)-폼의 치환된 사이클로프로판 카복실산 에스터만을 특이적으로 반응시켜 반응액 내에는 (S)-폼의 치환된 사이클로프로판 카복사미드와 (R)-폼의 치환된 사이클로프로판 카복실산 에스터가 존재하게 되며, 간단한 분리과정을 거쳐 (S)-폼의 치환된 사이클로프로판 카복사미드 화합물과 (R)-폼의 치환된 사이클로프로판 카복실산 에스터를 분리 할 수 있다. 이는 칸디다 안타크티카 유래의 리파제 가 (S)-사이클로프로판 카복실산 에스터 모핵 구조의 화합물을 특이적으로 반응시키는 것에서 기인하는 것이다.When the cyclopropane carboxylic acid ester racemate of the formula (3) of the present invention is reacted with a lipase enzyme in an organic solvent in which ammonia gas is dissolved, while maintaining the reaction temperature, only the substituted cyclopropane carboxylic acid ester of (S) -form is specific. In the reaction solution, the substituted cyclopropane carboxamide of (S) -form and the substituted cyclopropane carboxylic acid ester of (R) -form exist, and the (S) -form substitution is carried out through a simple separation process. The cyclopropane carboxamide compound may be separated from the substituted cyclopropane carboxylic acid ester of the (R) -form. This is due to the lipase derived from Candida anthracica specifically reacting the compound of the (S) -cyclopropane carboxylic acid ester nucleus structure.
광학분할에 이용되는 효소로서 리파제는 칸디다 실린드라시아 (Candida cylindracea), 슈도모나스 (Pseudomonas sp.), 칸디다 루고사 (Candida rugosa) 또는 칸디다 안타크티카 (Candida antarctica) 유래의 리파제 등 매우 범위가 넓으며, 그 소스(source)에 따라, 작용하는 화합물의 종류, 작용하는 광학 이성질체의 종류 및 반응성 등에서 차이가 있으며, 대부분의 리파제의 경우 전혀 반응을 하지 않거나 일부 가수분해가 진행된다 하더라도 광학순도가 떨어져 광학분할 효소로서의 의미가 없는 경우가 대부분이며, 본 발명자들은 효소에 의한 광학분할 반응에서 리파제로서 칸디다 안타크티카 (Candida antarctica) 유래의 리파제만이 매우 높은 전환율과 높은 광학순도를 얻을 수 있음을 발견하였다.As an enzyme used for optical splitting, lipases are very broad, including lipases from Candida cylindracea, Pseudomonas sp., Candida rugosa, or Candida antarctica. Depending on the source, there is a difference in the kind of the compound, the kind of optical isomers and the reactivity. In most cases, the lipase derived from Candida antarctica can obtain very high conversion and high optical purity in the optical splitting reaction by enzyme. .
효소 반응에 의한 광학분할은 하기의 반응식 1에 도시된 바와 같이 진행된다.Optical splitting by enzyme reaction proceeds as shown in Scheme 1 below.
[반응식 1]Scheme 1
상기 반응식 1에서 보는 바와 같이 사이클로프로판 카복실산 에스터 라세미체(3)는 사이클로프로판 카복실산 라세미체(4)를 다양한 알코올들과 에스터화 반응 에 의하여 용이하게 제조될 수 있다.As shown in Scheme 1, the cyclopropane carboxylic ester racemate 3 can be easily prepared by esterification of the cyclopropane carboxylic acid racemate 4 with various alcohols.
통상적인 에스터화 반응과 유사하게 유기용매 중에 사이클로프로판 카복실산 라세미체(4)를 넣고 티오닐클로라이드(SOCl2) 등을 적가하여 아실할라이드 등 이탈그룹이 치환된 화합물을 제조한 후 분리하지 않고 당해 반응혼합물에 2-클로로에탄올, 2,2-디클로로에탄올, 2,2,2-트리클로로에탄올, 2-플루오르에탄올, 2,2-디플루오르에탄올, 2,2,2-트리플루오르에탄올, 2-브로모에탄올, 2,2-디브로모에탄올, 2,2,2,-트리브로모에탄올 또는 2-메톡시에탄올로부터 선택되는 1종의 알코올 유도체를 첨가하여 제조하는 과정을 거쳐 사이클로프로판 카복실산 에스터 라세미체(3)를 85% 이상의 높은 수율로 제조할 수 있다. 제조된 사이클로프로판 카복실산 에스터 라세미체(3)에 효소로서 칸디다 안타크티카 유래의 리파제를 넣고 암모니아 가스가 용해된 유기용매 중에서 광학분할 반응을 진행한다.Similar to the conventional esterification reaction, cyclopropane carboxylic acid racemate (4) was added to an organic solvent and thionyl chloride (SOCl 2 ) was added dropwise to prepare a compound substituted with a leaving group such as acyl halide. 2-chloroethanol, 2,2-dichloroethanol, 2,2,2-trichloroethanol, 2-fluoroethanol, 2,2-difluoroethanol, 2,2,2-trifluoroethanol, 2- in the reaction mixture Cyclopropane carboxylic acid ester through the process of addition of one alcohol derivative selected from bromoethanol, 2,2-dibromoethanol, 2,2,2, -tribromoethanol or 2-methoxyethanol The racemate 3 can be produced in high yield of at least 85%. A lipase derived from Candida anthracica is added as an enzyme to the prepared cyclopropane carboxylic acid ester racemate (3), and optical split reaction is performed in an organic solvent in which ammonia gas is dissolved.
상기 유기용매는 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올, 이소아밀알코올, tert-부탄올, 펜탄올, 핵산올, 헵탄올, 옥탄올로부터 선택되는 알코올류 용매; 1,4-디옥산, 트리옥산으로부터 선택되는 옥산류 용매, 디에틸포름아미드, 디메틸포름아미이드로부터 선택되는 아미드류 용매, 디메틸술폭사이드, 벤젠, 톨루엔, 자일렌으로부터 선택되는 방향족 용매; 헥산, 헵탄, 옥탄, 사이클로헥산으로부터 선택되는 비극성 용매로부터 선택되는 1종 또는 2종 이상의 혼합인 것을 특징으로 한다.The organic solvent may be an alcohol solvent selected from methanol, ethanol, propanol, isopropanol, butanol, isoamyl alcohol, tert-butanol, pentanol, nucleic acidol, heptanol, and octanol; Oxane solvents selected from 1,4-dioxane and trioxane, amide solvents selected from diethylformamide, dimethylformamide, aromatic solvents selected from dimethyl sulfoxide, benzene, toluene, xylene; It is characterized by one or two or more kinds selected from non-polar solvents selected from hexane, heptane, octane, cyclohexane.
본 발명에 따른 칸디다 안타크티카 유래의 리파제에 의한 특이적 효소반응에 의한 광학분할 반응은 사이클로프로판 카복실산 모핵 구조를 갖는 카복실산 에스터 화합물 범위이면 모두 가능하며, 상기 화학식 1의 사이클로프로판의 2 위치에 어떠한 치환체라도 치환 가능하나, R1, R2는 서로 동일하거나 상이할 수 있으며, 수소, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알킬, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알케닐, 벤질, 치환되거나 치환되지 않은 C3 내지 C7의 사이클로알킬, 치환되거나 치환되지 않은 아릴알킬 또는 치환되거나 치환되지 않은 헤테로아릴알킬 중에서 선택되는 것이 바람직하며, R1, R2는 서로 동일하거나 상이할 수 있으며, 메틸, 에틸, n-프로필, i-프로필, n-부틸, n-펜틸, n-헥실, 플루오르메틸, 디플루오르메틸 또는 트리플루오르메틸로부터 선택될 때 본 발명에 따른 제조방법의 목적을 달성하는 데 바람직하며, R1, R2가 모두 메틸일 때 더욱 바람직하다.Optical splitting reaction by specific enzymatic reaction by a lipase derived from Candida anthracica according to the present invention can be performed within the range of the carboxylic acid ester compound having a cyclopropane carboxylic acid nucleus structure. Substituents may be substituted, but R 1 , R 2 may be the same or different from each other, and hydrogen, substituted or unsubstituted straight or branched C1 to C7 alkyl, substituted or unsubstituted straight or branched C1 to C7 Alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, or substituted or unsubstituted heteroarylalkyl is preferably selected, and R 1 , R 2 are the same or different from each other. Methyl, ethyl, n-propyl, i-propyl, n-butyl, n-pentyl, n-hexyl, fluoromethyl, It is preferred to achieve the object of the production process according to the invention when selected from difluoromethyl or trifluoromethyl, more preferably when both R 1 and R 2 are methyl.
또한 칸디다 안타크티카 유래의 리파제에 의한 특이적 효소반응에 의한 광학분할 반응에 있어서 가장 큰 영향을 미치는 것은 사이클로프로판 카복실산 에스터 라세미체의 R3 내지 R5 치환체의 특성이며, 본 발명에 따른 효소반응이 가능한 에스터 치환체의 범위로는 R3, R4가 서로 동일하거나 상이할 수 있으며, 수소, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알킬, 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알케닐, 벤질, 치환되거나 치환되지 않은 C3 내지 C7의 사이클로알킬, 치환되거나 치환되지 않은 아릴알킬 또는 치환되거나 치환되지 않은 헤테로아릴알킬 중에서 선택되며, R5는 C1 내지 C7의 직쇄 또는 측쇄의 알킬로부터 선택되는 것이 적절하며, R5 치환체의 1번 위치에 전자가 풍부한 원자로 치환되는 것이 본 발명에 따른 효소반응에 있어서, 광학 순도를 향상시키는데 바람직하며, 따라서 R5가 할로화합물로 치환된 C1 내지 C7의 직쇄 또는 측쇄의 알킬 또는 치환되거나 치환되지 않은 직쇄 또는 측쇄의 C1 내지 C7의 알콕시기가 치환된 C1 내지 C7의 직쇄 또는 측쇄의 알킬 중에서 선택되는 것이 바람직하다. 특히 R3, R4가 수소이고, R5는 플루오르메틸, 플루오르메틸, 디플루오르메틸, 트리플루오르메틸, 클로로메틸, 디클로로메틸, 트리클로로메틸, 브로모메틸, 디브로모메틸, 트리브로모메틸, 메톡시메틸 또는 에톡시메틸로부터 선택되는 것이 가장 바람직하다.In addition, the most significant influence in the optical splitting reaction by a specific enzyme reaction by lipase derived from Candida anthracica is the property of the R 3 to R 5 substituents of the cyclopropane carboxylic ester racemate, and the enzyme according to the present invention. The range of ester substituent that can be reacted may be the same or different from each other, R 3 , R 4 , hydrogen, substituted or unsubstituted straight or branched C1 to C7 alkyl, substituted or unsubstituted straight or branched C1 To alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, or substituted or unsubstituted heteroarylalkyl, R 5 is C1 to C7 straight or branched chain and is selected from alkyl of appropriate feet that are electron rich atoms is substituted in position 1 of the R 5 substituent present In the enzyme reaction in accordance with, it is preferred to improve the optical purity, and thus R 5 is halo compound substituted C1 to C1 to an alkoxy group substituted with a C7 of the straight-chain or alkyl or an optionally substituted straight or branched chain C7 to Preferably selected from C1 to C7 linear or branched alkyl. In particular R 3 , R 4 are hydrogen, R 5 is fluoromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl Most preferably, methoxymethyl or ethoxymethyl.
효소에 의한 특이적 효소반응에 의한 광학분할 반응에 사용되는 효소는 앞서 언급한 칸디다 안타크티카 유래의 리파제는 상용화되어 있어 용이하게 입수하여 사용가능하다. 반응계 내에서의 상기 칸디다 안타크티카 유래의 리파제의 농도는 기질인 사이클로프로판 카복실산 에스터 라세미체 기준으로 1 내지 30 중량%가 바람직하나, 5 중량% 내외가 더욱 바람직하며, 효소는 반응의 편의성 및 경제성을 위하여 고정화시킨 것을 사용하는 것이 바람직하다.The enzyme used in the optical splitting reaction by the specific enzyme reaction by the enzyme is commercialized and can be easily obtained and used as a lipase derived from Candida antarctica. The concentration of the lipase derived from Candida anthracica in the reaction system is preferably 1 to 30% by weight based on cyclopropane carboxylic acid ester racemate, which is about 5% by weight, and more preferably about 5% by weight of the enzyme. It is preferable to use immobilized for economics.
본 발명에 따른 칸디다 안타크티카 유래의 리파제에 의한 특이적 효소반응에 의한 사이클로프로판 카복실산의 광학분할 반응은 반응온도를 일정하게 유지시키면서 반응시키게 되며, 이때 반응온도는 10 내지 80℃가 바람직하며, 광학순도를 고 려하면 반응온도는 20 내지 45℃가 가장 바람직하다.The optical splitting reaction of cyclopropane carboxylic acid by a specific enzyme reaction by lipase derived from Candida anthracica according to the present invention is carried out while keeping the reaction temperature constant, wherein the reaction temperature is preferably 10 to 80 ° C. Considering the optical purity, the reaction temperature is most preferably 20 to 45 ° C.
효소에 의한 광학분할 반응시 기질로 사용하는 사이클로프로판 카복실산 에스터 라세미체의 농도는 3 % 내지 70 %가 적절하며, 공정의 효율성 등을 고려할 때 5 % 내지 40 %가 바람직하다.The concentration of cyclopropane carboxylic acid ester racemate used as a substrate in the optical splitting reaction by enzyme is preferably 3% to 70%, and 5% to 40% is preferable in consideration of process efficiency and the like.
본 발명에 따른 방법은 효소에 의한 특이적 효소반응에 의한 광학분할 반응 후 간단한 후처리 공정에 의하여 광학활성물질인 사이클로프로판 카복사미드 및 사이클로프로판 카복실산 에스터를 분리하여 얻을 수 있다.The method according to the present invention can be obtained by separating the optically active materials cyclopropane carboxamide and cyclopropane carboxylic acid ester by a simple post-treatment process after the optical splitting reaction by an enzyme-specific enzyme reaction.
반응 혼합용액을 여과하여 효소를 회수하고, 여과액에서 유기용매 및 저비점 유기물을 증류시켜 회수하여 (S)-2,2-디메틸사이클로프로판 카복사미드를 수득하며, 상기 얻어진 (S)-2,2-디메틸사이클로프로판 카복사미드의 순도 및 광학순도를 높이기 위하여 메탄올 하에서 재결정하여 정제한다.The reaction mixture was filtered to recover the enzyme, and the organic solvent and the low boiling organic substance were recovered by distillation from the filtrate to obtain (S) -2,2-dimethylcyclopropane carboxamide, and the obtained (S) -2, To increase the purity and optical purity of 2-dimethylcyclopropane carboxamide, it is recrystallized and purified under methanol.
효소반응에서 사용한 효소는 반응 종료 후 필터 등의 수단에 의하여 분리 후 세척하여 다시 사용할 수 있다.The enzyme used in the enzyme reaction can be washed again after separation by means of a filter or the like after the completion of the reaction.
이하 실시 예에 의하여 본 발명을 보다 상세히 설명하고자 한다. 본 발명의 범위가 이들 실시 예에 의하여 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. The scope of the present invention is not limited by these examples.
[제조예 1] 치환된 사이클로프로판 카복실산 2,2,2-트리플루오르에틸 에스터의 제조Preparation Example 1 Preparation of Substituted Cyclopropane Carboxylic Acid 2,2,2-Trifluoroethyl Ester
반응기에 메틸렌클로라이드 500 ml, 디메틸사이클로프로판 카복실산 228 g을 넣고, 상온에서 잘 섞어준 뒤, 온도를 20 ℃로 유지하면서, 티오닐클로라이드(SOCl2) 236 g을 천천히 적가 하였다. 상온에서 1시간 더 교반한 뒤에, 2,2,2-트리플루오르에탄올(2,2,2-trifluoroethanol) 190 g을 천천히 적가하고, 상온에서 2시간 더 교반하였다. 포화된 소듐카보네이트(Na2CO3) 용액으로 세척 후 무수 소듐설페이트(Na2SO4)로 건조 후 감압 증류시켜 유기용매를 제거하여, 표제의 디메틸사이클로프로판 카복실산 2,2,2-트리플루오르에틸 에스터 라세미체 화합물 340 g(수율 87%)을 회수하였다.500 ml of methylene chloride and 228 g of dimethylcyclopropane carboxylic acid were added to the reactor, mixed well at room temperature, and 236 g of thionyl chloride (SOCl 2 ) was slowly added dropwise while maintaining the temperature at 20 ° C. After further stirring at room temperature for 1 hour, 190 g of 2,2,2-trifluoroethanol was slowly added dropwise and stirred at room temperature for 2 hours. After washing with saturated sodium carbonate (Na 2 CO 3 ) solution, drying with anhydrous sodium sulfate (Na 2 SO 4 ) and distilling under reduced pressure to remove the organic solvent, the title dimethylcyclopropane carboxylic acid 2,2,2-trifluoroethyl 340 g (87% yield) of ester racemate compound were recovered.
[제조예 2 내지 5] 디메틸사이클로프로판 카복실산 에스터 라세미체 제조Preparation Example 2 to 5 Preparation of Dimethylcyclopropane Carboxylic Acid Ester Racemate
알코올 종류를 2,2,2-트리클로로에탄올(제조예 2), 2-메톡시에탄올(제조예 3), 2-브로모에탄올(제조예 4), 2-클로로에탄올(제조예 5)로 달리하여 제조예 1과 동일한 방법으로 여러 종류의 디메틸사이클로프로판 카복실산 에스터 라세미체를 제조하였다. 그 결과는 표 1에 나타내었다.Alcohol type was 2,2,2-trichloroethanol (preparation example 2), 2-methoxyethanol (preparation example 3), 2-bromoethanol (preparation example 4), 2-chloroethanol (preparation example 5) Differently, various kinds of dimethylcyclopropane carboxylic acid ester racemates were prepared in the same manner as in Preparation Example 1. The results are shown in Table 1.
[표 1]TABLE 1
[실시예 1] 효소 선별Example 1 Enzyme Screening
암모니아 가스로 포화된 t-부탄올(t-butanol) 1 ml에 제조예 1에서 제조한 디메틸사이클로프로판 카복실산 2,2,2-트리플루오르 에스터 라세미체 50 mg(5 %), 효소로서 칸디다 안타크티카 유래의 리파제인 칸디다 안타크디카 타입B 리파제 2.5 mg을 넣고 30 ℃에서 20시간 반응시킨 후 반응액 0.2 ml을 취해 키랄 칼럼이 장착된 가스크로마토그래피를 이용하여 광학순도를 측정하였다.50 mg (5%) of dimethylcyclopropane carboxylic acid 2,2,2-trifluoroester racemate prepared in Preparation Example 1 in 1 ml of t-butanol saturated with ammonia gas, Candida anthac as enzyme 2.5 mg of candida anthacdica type B lipase, a lipase derived from tika, was reacted at 30 ° C. for 20 hours, and 0.2 ml of the reaction solution was measured for optical purity using gas chromatography equipped with a chiral column.
[비교예 1 내지 비교예 15] 효소에 따른 입체특이적 효소반응의 비교Comparative Example 1 to Comparative Example 15 Comparison of Stereospecific Enzyme Reactions According to Enzymes
본 발명에 따른 제조방법에서 사용하는 효소인 칸디다 안타크티카 유래의 리파제인 칸디다 안타크디카 타입B 리파제와 기타 다른 효소의 종류에 따른 (S)-디메틸사이클로프로판 카복사미드 광학이성질체의 전환율과 광학순도를 비교하기 위하여 표 2에 기재된 바에 따른 효소의 종류를 달리한 것 이외에는 실시예 1과 동일한 조건으로 반응을 수행하였다.Conversion rate and optical properties of the (S) -dimethylcyclopropane carboxamide optical isomer according to the Candida anthacdica type B lipase, a lipase derived from Candida anthracica, an enzyme used in the preparation method according to the present invention, and other enzymes In order to compare the purity, the reaction was carried out under the same conditions as in Example 1 except for changing the types of enzymes as described in Table 2.
[표 2]TABLE 2
상기 표 2에서 알 수 있는 바와 같이 2,2-디메틸사이클로프로판 카복실산 2,2,2-트리플루오르에틸 에스터 라세미체를 기질로 효소를 스크리닝한 결과 칸디다 안타크디카 타입B 리파제 (실시예 1)가 유일하게 산업적으로 유용한 정도의 높은 광학순도로 (S)-디메틸사이클로프로판 카복사미드 광학이성질체의 생성을 보였으 며, 다른 리파제, 프로테아제 및 에스터라제는 전혀 반응이 진행되지 않았고, 따라서 본 발명에 따른 제조방법의 효소인 칸디다 안타크티카 유래 리파제의 입체특이적 효소로서의 현저한 작용효과를 확인할 수 있었다.As can be seen in Table 2, the enzyme was screened with 2,2-dimethylcyclopropane carboxylic acid 2,2,2-trifluoroethyl ester racemate as a substrate. Only showed the production of (S) -dimethylcyclopropane carboxamide optical isomer with high optical purity of industrial usefulness, and other lipases, proteases and esterases did not proceed at all, and thus Significant effects of the candida antarctica-derived lipase, an enzyme of the preparation method, as a stereospecific enzyme could be confirmed.
[실시예 2] 2,2-디메틸사이클로프로판 카복실산 2,2,2-트리클로로에틸 에스터의 효소 반응Example 2 Enzymatic Reaction of 2,2-Dimethylcyclopropane Carboxylic Acid 2,2,2-Trichloroethyl Ester
치환된 알코올 종류별 효소반응을 비교하기 위하여 상기 제조예 2에서 제조한 2,2-디메틸사이클로프로판 카복실산 2,2,2-트리클로로에틸 에스터를 기질로 한 것 외에는 상기 실시예 1의 방법으로 (S)-2,2-디메틸사이클로프로판 카복사미드 광학이성체를 제조하였다.In order to compare the enzyme reaction for each type of substituted alcohol by the method of Example 1 except for using the 2,2-dimethylcyclopropane carboxylic acid 2,2,2-trichloroethyl ester prepared in Preparation Example 2 (S ) -2,2-dimethylcyclopropane carboxamide optical isomer was prepared.
[실시예 3] 2,2-디메틸사이클로프로판 카복실산 2-메톡시에틸 에스터의 효소 반응Example 3 Enzymatic Reaction of 2,2-Dimethylcyclopropane Carboxylic Acid 2-methoxyethyl Ester
치환된 알코올 종류별 효소반응을 비교하기 위하여 상기 제조예 3에서 제조한 2,2-디메틸사이클로프로판 카복실산 2-메톡시에틸 에스터를 기질로 한 것 외에는 상기 실시예 1의 방법으로 (S)-2,2-디메틸사이클로프로판 카복사미드 광학이성체를 제조하였다.In order to compare the enzyme reaction for each type of substituted alcohol by the method of Example 1 except for using the substrate 2,2-dimethylcyclopropane carboxylic acid 2-methoxyethyl ester prepared in Preparation Example 3 (S) -2, 2-Dimethylcyclopropane carboxamide optical isomer was prepared.
[실시예 4] 2,2-디메틸사이클로프로판 카복실산 2-브로모에틸 에스터의 효소 반응Example 4 Enzymatic Reaction of 2,2-Dimethylcyclopropane Carboxylic Acid 2-bromoethyl Ester
치환된 알코올 종류별 효소반응을 비교하기 위하여 상기 제조예 4에서 제조한 2,2-디메틸사이클로프로판 카복실산 2-브로모에틸 에스터를 기질로 한 것 외에는 상기 실시예 1의 방법으로 (S)-2,2-디메틸사이클로프로판 카복사미드 광학이성체를 제조하였다.In order to compare the enzyme reaction for each type of substituted alcohol by the method of Example 1 except for using the substrate 2,2-dimethylcyclopropane carboxylic acid 2-bromoethyl ester prepared in Preparation Example 4 (S) -2, 2-Dimethylcyclopropane carboxamide optical isomer was prepared.
[실시예 5] 2,2-디메틸사이클로프로판 카복실산 2-클로로에틸 에스터의 효소 반응Example 5 Enzymatic Reaction of 2,2-Dimethylcyclopropane Carboxylic Acid 2-Chloroethyl Ester
치환된 알코올 종류별 효소반응을 비교하기 위하여 상기 제조예 5에서 제조한 2,2-디메틸사이클로프로판 카복실산 2-클로로에틸 에스터를 기질로 한 것 외에는 상기 실시예 1의 방법으로 (S)-2,2-디메틸사이클로프로판 카복사미드 광학이성체를 제조하였다.In order to compare the enzyme reaction for each type of substituted alcohol by the method of Example 1 except for using the 2,2-dimethylcyclopropane carboxylic acid 2-chloroethyl ester prepared in Preparation Example 5 as a substrate (S) -2,2 -Dimethylcyclopropane carboxamide optical isomer was prepared.
상기 실시예 2 내지 실시예 5의 치환된 알코올 종류별 효소반응의 결과를 표 3에 나타내었다.Table 3 shows the results of the enzymatic reactions of the substituted alcohols of Examples 2 to 5.
[표 3]TABLE 3
[실시예 6] (S)-2,2-디메틸사이클로프로판 카복사미드의 제조Example 6 Preparation of (S) -2,2-dimethylcyclopropane carboxamide
10g 의 2,2-디메틸사이클로프로판 카복실산 2,2,2-트리플루오르에틸 에스터 라세미체를 t-부탄올 100ml에 녹인 후 40℃를 유지하면서, 암모니아 가스를 40분간 흘려주어 암모니아 가스가 혼합용액에 포화되도록 하였다. 상기의 온도를 그대로 유지하면서, 2 g의 칸디다 안타크디카 타입B 리파제를 상기 혼합용액에 넣고 일정 속도로 교반하여 반응시켰다. 반응이 종결된 후 반응 혼합용액을 여과하여 효소를 회수하고, 여과액에서 유기용매 및 저비점 유기물을 증류시켜 회수하여 (S)-2,2-디메틸사이클로프로판 카복사미드를 수득하였다. 얻어진 (S)-2,2-디메틸사이클로프로판 카복사미드의 순도 및 광학순도를 높이기 위하여 메탄올 하에서 재결정하여 정제된 백색분말의 표제의 (S)-2,2-디메틸사이클로프로판 카복사미드(수율:40%, 광학순도:99%)를 수득하였다.After dissolving 10 g of 2,2-dimethylcyclopropane carboxylic acid 2,2,2-trifluoroethyl ester racemate in 100 ml of t-butanol and maintaining 40 ° C, ammonia gas was flowed for 40 minutes and ammonia gas was added to the mixed solution. It was allowed to saturate. While maintaining the temperature as it is, 2 g of Candida anthacdica type B lipase was added to the mixed solution and stirred at a constant speed to react. After completion of the reaction, the reaction mixture was filtered to recover the enzyme, and the organic solvent and the low boiling point organics were recovered by distillation to obtain (S) -2,2-dimethylcyclopropane carboxamide. The titled (S) -2,2-dimethylcyclopropane carboxamide (yield) of the white powder purified by recrystallization in methanol in order to increase the purity and optical purity of the obtained (S) -2,2-dimethylcyclopropane carboxamide. : 40%, optical purity: 99%) was obtained.
본 발명에 따른 제조방법은 종래의 광학활성을 갖는 아민류나 L-멘톨 같은 값비싼 광학분할제를 사용하거나 복잡한 발효공정을 사용하지 않고 고농도에서 가수분해 효소를 반응시켜 (S)-사이클로프로판 카복사미드 유도체를 높은 광학순도, 고수율의 산업적으로 경제성이 있는 새로운 제조방법을 제공할 수 있는 장점이 있다.The preparation method according to the present invention uses (S) -cyclopropane carcopy by reacting the hydrolase at high concentration without using expensive optical splitting agents such as amines or L-menthol having conventional optical activity or complex fermentation process. The medi derivative has the advantage of providing a new manufacturing method of high economic purity, high yield industrially economical.
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050122129A KR100650797B1 (en) | 2005-12-12 | 2005-12-12 | Method for preparing optically active cyclopropane carboxamide |
AT0951906A AT509135A1 (en) | 2005-12-12 | 2006-12-12 | PROCESS FOR PREPARING OPTICALLY ACTIVE CYCLOPROPANCARBOXAMIDE AND DERIVATIVES THEREOF |
PCT/KR2006/005402 WO2007069841A1 (en) | 2005-12-12 | 2006-12-12 | Process for preparing optically active cyclopropane carboxamide and derivatives thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050122129A KR100650797B1 (en) | 2005-12-12 | 2005-12-12 | Method for preparing optically active cyclopropane carboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100650797B1 true KR100650797B1 (en) | 2006-11-27 |
Family
ID=37713941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050122129A Expired - Fee Related KR100650797B1 (en) | 2005-12-12 | 2005-12-12 | Method for preparing optically active cyclopropane carboxamide |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100650797B1 (en) |
AT (1) | AT509135A1 (en) |
WO (1) | WO2007069841A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100884558B1 (en) | 2008-09-11 | 2009-02-19 | 디에이치씨 (주) | Process for preparing optically active amide of high yield and high optical purity |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2817412B1 (en) * | 2012-02-24 | 2018-12-26 | Bristol-Myers Squibb Company | Process for resolving cyclopropyl diesters |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273903A (en) | 1991-03-06 | 1993-12-28 | Lonza Ltd. | Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide |
US5427934A (en) | 1991-07-26 | 1995-06-27 | Lonza Ltd. | Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
KR20040004744A (en) * | 2002-07-05 | 2004-01-14 | 임광민 | Amide compound, process for the production |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9711566B (en) * | 1996-12-27 | 1998-06-29 | Smithkline Beecham Plc | Enzymatic resolution. |
US7264960B2 (en) * | 2002-03-22 | 2007-09-04 | Dow Global Technologies Inc. | Enzymatic resolution of propylene glycol alkyl (or aryl) ethers and ether acetates |
-
2005
- 2005-12-12 KR KR1020050122129A patent/KR100650797B1/en not_active Expired - Fee Related
-
2006
- 2006-12-12 AT AT0951906A patent/AT509135A1/en not_active Application Discontinuation
- 2006-12-12 WO PCT/KR2006/005402 patent/WO2007069841A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273903A (en) | 1991-03-06 | 1993-12-28 | Lonza Ltd. | Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide |
US5360731A (en) | 1991-03-06 | 1994-11-01 | Lonza Ltd. | Bacteria capable of stereospecifically hydrolyzing R-(-)-2,2-dimethylcyclopropanecarboxamide |
US5427934A (en) | 1991-07-26 | 1995-06-27 | Lonza Ltd. | Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
KR20040004744A (en) * | 2002-07-05 | 2004-01-14 | 임광민 | Amide compound, process for the production |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100884558B1 (en) | 2008-09-11 | 2009-02-19 | 디에이치씨 (주) | Process for preparing optically active amide of high yield and high optical purity |
Also Published As
Publication number | Publication date |
---|---|
WO2007069841A1 (en) | 2007-06-21 |
AT509135A1 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5728876A (en) | Resolution of the racemates of primary and secondary amines by enzyme-catalyzed acylation | |
KR100650797B1 (en) | Method for preparing optically active cyclopropane carboxamide | |
JP2006510364A (en) | A method for preparing (R) or (S) N- (2,6-dimethylphenyl) alanine and its opposite enantiomer N- (2,6-dimethylphenyl) alanine using an enzyme | |
EP0890649B1 (en) | Process for the preparation of acylated amino acid esters and resolving racemic mixtures of amino acid esters by enzyme-catalysed acylation | |
KR100423875B1 (en) | Method for preparing chiral amines | |
KR100511534B1 (en) | Amide compound, process for the production | |
Milner et al. | Efficient kinetic bioresolution of 2-nitrocyclohexanol | |
EP0529085A1 (en) | Process for producing optically active 3-chloro-1-phenyl-1-propanol and derivative thereof | |
KR100650798B1 (en) | Method for preparing optically active carboxylic acid | |
JP4843813B2 (en) | Method for preparing R- or S-form α-substituted heterocyclic carboxylic acid and enantiomer of α-substituted heterocyclic carboxylic acid ester of the opposite mirror image using enzyme | |
US6455302B1 (en) | Method for optically resolving a racemic α-substituted heterocyclic carboxylic acid using enzyme | |
EP0474250A2 (en) | Enzymatic process for separating the optical isomers of racemic 1,2-diols | |
EP0239122B1 (en) | Process for the enzymatic resolution of racemic 2-amino-1-alkanols | |
EP0556909B1 (en) | Process for separating 1,2-isopropylideneglycerol benzoyl ester enantiomers | |
JP3704731B2 (en) | Process for producing optically active 3-hydroxyhexanoic acids | |
KR100368735B1 (en) | Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme | |
KR100359028B1 (en) | Method for preparing chiral allyl ester | |
JP2612671B2 (en) | Method for producing optically active propionate | |
EP1428888B1 (en) | Method for the production of (1S,4R)-(-)-4-Hydroxycyclopent-2-enyl esters | |
DE4414273A1 (en) | Optical resolution of racemic alcohols | |
KR100651393B1 (en) | Method for preparing (R) -1-amino-2-propanol using hydrolase | |
JP3970898B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
KR100688905B1 (en) | Method for preparing al-2-acyloxy-1-arylpropanone and s-2-hydroxy-1-arylpropanone derivative from racemic 2-hydroxy-1-arylpropanone derivative using lipase | |
WO1993002207A1 (en) | Stereoselective synthesis of alcohols | |
JPH07115992A (en) | Enzymatic production of optically active compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20051212 |
|
PA0201 | Request for examination | ||
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20060317 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20061114 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20061121 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20061122 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20091109 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20101122 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20101122 Start annual number: 5 End annual number: 5 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20121009 |